Clinical Trial: A Randomized, Double-Blind Trial of the Neuclare Device for Temporary Improvement of Executive Function in Patients With Mild Cognitive Impairment and Prodromal Alzheimer's Disease.

U.S., Nov. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07239310) titled 'A Randomized, Double-Blind Trial of the Neuclare Device for Temporary Improvement of Executive Function in Patients With Mild Cognitive Impairment and Prodromal Alzheimer's Disease.' on Nov. 16.

Brief Summary: This study is a multicenter, randomized, double-blind, parallel-group, prospective confirmatory clinical trial designed to evaluate whether the Neuclare medical device can temporarily improve executive function (planning and problem-solving abilities) in adults with mild cognitive impairment or very early Alzheimer's disease.

Participants will continue their current medication and be randomly assigned to receive either the Ne...